Archive

ASH 2015: Prognostic score helps assess chances of progression-free survival in HL autologous transplant recipients

by Thomas R. Collins: Researchers have developed a prognostic “score” to gauge the chances of progression-free survival in patients with relapsed or refractory Hodgkin lymphoma who have had… read more.

ASH 2015: Highlights of the 57th American Hematological Society Meeting. Professor Ajay Gopal (Seattle Cancer Care Alliance), Professor Stephen Ansell (Mayo Clinic), Professor John Sweetenham (Huntsman Cancer Institute) and Professor Joseph Connors (Vancouver) share their highlights of a very busy ASH and New Year’s resolutions for their management of lymphoma in 2016. Click video image to view.

ESOT 2015: Tailored self-management interventions for vulnerable populations

by Maria Dalby: Self-management after undergoing transplantation requires skills and confidence both with respect to taking medications, adhering to medical advice and coping with everyday life.

Benefits for COPD patients using digital health application

Early intervention facilitated by a digital health application for reporting symptoms of Chronic Obstructive Pulmonary Disease (COPD) provides key benefits for patients, according to the results of a… read more.

A person’s diet, acidity of urine may affect susceptibility to UTIs

The acidity of urine — as well as the presence of small molecules related to diet — may influence how well bacteria can grow in the urinary tract,… read more.

High blood pressure linked to reduced Alzheimer’s risk, meds may be reason

A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.

High blood pressure linked to reduced Alzheimer's risk, meds may be reason

A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.

ASCO 2015 Report: Pembrolizumab shows “remarkable” efficacy in head and neck cancer

by Bruce Sylvester: Pembrolizumab (Keytruda®), an anti-PD-1 antibody immunotherapy has shown efficacy in one fourth of patients with recurrent or metastatic head and neck cancer, researchers reported on… read more.

Diabetes drug may reduce heart attack risk in HIV patients

In patients with HIV, a diabetes drug may have benefits beyond lowering blood sugar. A new study from researchers at Washington University School of Medicine in St. Louis… read more.

Men far less likely to prevent, screen for osteoporosis

While the consequences of osteoporosis are worse in men than women – including death – older males are far less likely to take preventive measures against the potentially… read more.

Variance in BRCA1, BRCA2 mutations appear to be behind differing risks of breast and ovarian cancers

by Bruce Slyvester: Among a large group of women who carry disease-associated mutations in BRCA1 or BRCA2 genes, genetic mutations appear to be associated with significantly different risks of developing breast… read more.

Review of global guidelines for sepsis needed

Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission… read more.